---
layout: post
title: "诚志股份：公司D核糖可用于生产抗冠状病毒药物的原料"
date: 2022-01-24 15:18:54 +0800
categories: zhengquanshibao
tags: 证券时报新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.000990" data-code="000990|0|2" data-code2="000990|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.000990&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 000990_0" data-code="K 000990|0|2" data-code2="K 000990|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>诚志股份(000990)在互动平台表示，公司生产的D核糖可以用于生产抗冠状病毒药物的原料，比如瑞德西韦和莫匹拉韦。</p><p class="em_media">（文章来源：证券时报）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202201242258862752>

[返回证券时报新闻](//finews.withounder.com/category/zhengquanshibao.html)｜[返回首页](//finews.withounder.com/)